Atypical CLN2 disease, TPP1 enzyme deficiency with disease onset and/or progression distinct from classic late‐infantile CLN2, represents 13% of individuals recorded with associated phenotype. This evidence concerns the gene TPP1 and hyperinsulinemic hypoglycemia, familial, 4.